[HTML][HTML] Morphea: progress to date and the road ahead

L Abbas, A Joseph, E Kunzler… - Annals of translational …, 2021 - ncbi.nlm.nih.gov
Morphea is a rare autoimmune condition causing inflammation and sclerosis of the skin and
underlying soft tissue. It is characterized by periods of activity (inflammation admixed with …

[HTML][HTML] Morphea: the 2023 update

C Papara, DA De Luca, K Bieber, A Vorobyev… - Frontiers in …, 2023 - frontiersin.org
Morphea, also known as localized scleroderma, is a chronic inflammatory connective tissue
disorder with variable clinical presentations, affecting both adults and children. It is …

Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma

SC Li, KS Torok, SS Ishaq, M Buckley, B Edelheit… - …, 2021 - academic.oup.com
Objective To evaluate the safety and efficacy of abatacept treatment for refractory juvenile
localized scleroderma (jLS) in a retrospective study. Methods A multicentre cohort study was …

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes

R Knobler, M Geroldinger‐Simić… - Journal of the …, 2024 - Wiley Online Library
The term 'sclerosing diseases of the skin'comprises specific dermatological entities, which
have fibrotic changes of the skin in common. These diseases mostly manifest in different …

Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments

SC Li - Current Opinion in Rheumatology, 2022 - journals.lww.com
Methotrexate treatment has greatly improved outcome for most jLS patients but a substantial
portion have refractory cutaneous and/or extracutaneous disease. Treatment response …

Immunologic underpinnings and treatment of morphea

AH LaChance, N Goldman, B Kassamali… - Expert Review of …, 2022 - Taylor & Francis
Introduction Morphea is a chronic autoimmune fibrosing condition of the skin and underlying
tissue with the potential for significant disease-associated morbidity. While the exact etiology …

Juvenile localized scleroderma: updates and differences from adult-onset disease

N Vasquez-Canizares, SC Li - Rheumatic Disease Clinics, 2021 - rheumatic.theclinics.com
Localized scleroderma (LS), also known as morphea, is an idiopathic inflammatory and
sclerosing disorder affecting the skin and subcutaneous structures. 1, 2 Although skin …

Clinical and therapeutic course in head variants of linear morphea in adults: a retrospective review

W Fan, B Obiakor, R Jacobson, A Haemel… - Archives of …, 2023 - Springer
Abstract Parry Romberg Syndrome (PRS) and en coup de sabre (ECDS) are head variants
of linear morphea with functional and structural implications. This study describes the clinical …

S2k‐Leitlinie: Diagnostik und Therapie der zirkumskripten Sklerodermie

A Kreuter, P Moinzadeh, M Kinberger… - JDDG: Journal der …, 2024 - Wiley Online Library
Die vorliegende aktualisierte S2k‐Leitlinie befasst sich mit der Diagnostik und der Therapie
der zirkumskripten Sklerodermie (ZS). Diese umfasst ein Spektrum sklerotischer …

Pediatric morphea state‐of‐the‐art literature review: Reframing morphea as a systemic disease

JR Sink, YE Chiu - Pediatric Dermatology, 2021 - Wiley Online Library
Pediatric morphea is an inflammatory, fibrosing dermatologic disorder. Although morphea
may be localized to the skin and subcutaneous tissues, differentiating it from systemic …